Christine Lindenboom | Vice President-Investor Relations and Corporate Communications |
John Maraganore | Chief Executive Officer |
Akshay Vaishnaw | Executive Vice President-R&D |
Manmeet Soni | Chief Financial Officer |
Barry Greene | President |
Yvonne Greenstreet | Executive Vice President and Chief Operating Officer |
Ted Tenthoff | Piper Jaffray |
Terence Flynn | Goldman Sachs |
Vincent Chen | Bernstein |
Madhu Kumar | B. Riley |
Alethia Young | Credit Suisse |
Maurice Raycroft | Jefferies |
Ladies and gentlemen, thank you for standing by. Welcome to the Alnylam Pharmaceuticals Conference Call to discuss the Fourth Quarter and Year End 2017 Financial Results. [Operator Instructions] Please be advised that this call is being taped at the Company's request. I would now like to turn the call over to the Company.
Good afternoon.